Mireille Sanders
Director de Operaciones en PHARMING GROUP N.V. .
Fortuna: 748 842 $ al 30/04/2024
Cargos activos de Mireille Sanders
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| PHARMING GROUP N.V. | Director de Operaciones | 15/12/2020 | - |
| Corporate Officer/Principal | 01/05/2019 | 15/12/2020 |
Historial de carrera de Mireille Sanders
Antiguos cargos conocidos de Mireille Sanders.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
Janssen Pharmaceuticals, Inc.
 Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | Corporate Officer/Principal | 01/01/2016 | 01/01/2019 |
Formación de Mireille Sanders.
| Technische Universiteit Eindhoven | Graduate Degree |
Estadísticas
Internacional
| Países Bajos | 3 |
| Estados Unidos | 2 |
Operativa
| Corporate Officer/Principal | 2 |
| Chief Operating Officer | 1 |
| Graduate Degree | 1 |
Sectorial
| Health Technology | 3 |
| Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| PHARMING GROUP N.V. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Janssen Pharmaceuticals, Inc.
Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | Health Technology |
- Bolsa de valores
- Insiders
- Mireille Sanders
- Experiencia
